Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lasers, Solid-State | 5 | 2020 | 175 | 1.880 |
Why?
|
Vitreous Body | 9 | 2020 | 398 | 1.600 |
Why?
|
Vitrectomy | 10 | 2020 | 385 | 1.420 |
Why?
|
Eye Diseases | 4 | 2020 | 655 | 1.390 |
Why?
|
Retinal Detachment | 7 | 2018 | 422 | 1.370 |
Why?
|
Eye Infections, Bacterial | 6 | 2021 | 234 | 1.130 |
Why?
|
Endophthalmitis | 7 | 2021 | 253 | 1.040 |
Why?
|
Laser Therapy | 5 | 2020 | 1099 | 0.990 |
Why?
|
Retinal Perforations | 4 | 2017 | 134 | 0.970 |
Why?
|
Angiogenesis Inhibitors | 12 | 2021 | 2040 | 0.940 |
Why?
|
Visual Acuity | 21 | 2020 | 2608 | 0.870 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 5 | 2016 | 664 | 0.720 |
Why?
|
Intravitreal Injections | 12 | 2021 | 380 | 0.690 |
Why?
|
Scleral Buckling | 4 | 2016 | 96 | 0.610 |
Why?
|
Diabetic Retinopathy | 3 | 2016 | 1258 | 0.610 |
Why?
|
Vitreoretinal Surgery | 1 | 2017 | 28 | 0.590 |
Why?
|
Timolol | 2 | 2020 | 51 | 0.580 |
Why?
|
Macula Lutea | 2 | 2016 | 166 | 0.580 |
Why?
|
Endotamponade | 3 | 2017 | 36 | 0.570 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2018 | 355 | 0.560 |
Why?
|
Macular Edema | 4 | 2020 | 375 | 0.560 |
Why?
|
Retinal Diseases | 5 | 2021 | 699 | 0.520 |
Why?
|
Ophthalmology | 1 | 2022 | 541 | 0.520 |
Why?
|
Recombinant Fusion Proteins | 5 | 2016 | 3726 | 0.500 |
Why?
|
Retinal Neoplasms | 1 | 2015 | 144 | 0.450 |
Why?
|
Wet Macular Degeneration | 4 | 2020 | 161 | 0.440 |
Why?
|
Sulfur Hexafluoride | 2 | 2013 | 26 | 0.430 |
Why?
|
Retinoblastoma | 1 | 2015 | 316 | 0.430 |
Why?
|
Thiophenes | 2 | 2020 | 587 | 0.420 |
Why?
|
Ophthalmic Solutions | 2 | 2020 | 305 | 0.400 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2021 | 3471 | 0.380 |
Why?
|
Dacryocystitis | 1 | 2011 | 70 | 0.370 |
Why?
|
Foreign-Body Migration | 1 | 2011 | 219 | 0.330 |
Why?
|
Eyelid Diseases | 1 | 2011 | 163 | 0.330 |
Why?
|
Uveal Neoplasms | 3 | 2009 | 335 | 0.320 |
Why?
|
Silicone Oils | 1 | 2008 | 22 | 0.310 |
Why?
|
Chorioretinitis | 1 | 2008 | 43 | 0.300 |
Why?
|
Sickness Impact Profile | 2 | 2020 | 298 | 0.290 |
Why?
|
Sulfonamides | 2 | 2020 | 1972 | 0.290 |
Why?
|
Eye Infections, Fungal | 1 | 2008 | 100 | 0.280 |
Why?
|
Fibrinolysin | 2 | 2016 | 131 | 0.260 |
Why?
|
Pigment Epithelium of Eye | 1 | 2006 | 211 | 0.260 |
Why?
|
Uvea | 1 | 2005 | 30 | 0.260 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2010 | 548 | 0.260 |
Why?
|
Candidiasis | 1 | 2008 | 357 | 0.250 |
Why?
|
Optic Nerve Diseases | 2 | 2021 | 342 | 0.240 |
Why?
|
Choroidal Neovascularization | 3 | 2020 | 357 | 0.240 |
Why?
|
Gases | 2 | 2017 | 203 | 0.230 |
Why?
|
Prostheses and Implants | 1 | 2011 | 1272 | 0.230 |
Why?
|
Tomography, Optical Coherence | 10 | 2021 | 2849 | 0.220 |
Why?
|
Intraocular Pressure | 4 | 2020 | 1283 | 0.210 |
Why?
|
Internet | 1 | 2014 | 3073 | 0.200 |
Why?
|
Drug Substitution | 2 | 2016 | 294 | 0.200 |
Why?
|
Vitreous Detachment | 2 | 2021 | 22 | 0.200 |
Why?
|
Retinal Hemorrhage | 1 | 2021 | 95 | 0.190 |
Why?
|
Investments | 1 | 2022 | 147 | 0.180 |
Why?
|
Macular Degeneration | 4 | 2011 | 999 | 0.180 |
Why?
|
Ultraviolet Rays | 1 | 2005 | 1076 | 0.180 |
Why?
|
Cryosurgery | 2 | 2016 | 466 | 0.170 |
Why?
|
Syringes | 1 | 2018 | 57 | 0.160 |
Why?
|
Exudates and Transudates | 4 | 2020 | 175 | 0.160 |
Why?
|
Aqueous Humor | 3 | 2017 | 154 | 0.160 |
Why?
|
Fundus Oculi | 3 | 2016 | 537 | 0.160 |
Why?
|
Epiretinal Membrane | 1 | 2018 | 72 | 0.150 |
Why?
|
Fovea Centralis | 1 | 2018 | 126 | 0.150 |
Why?
|
Telemedicine | 1 | 2014 | 2977 | 0.140 |
Why?
|
Fluorescein Angiography | 5 | 2021 | 1034 | 0.140 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39179 | 0.140 |
Why?
|
Observation | 1 | 2018 | 311 | 0.140 |
Why?
|
Melanoma | 4 | 2010 | 5658 | 0.130 |
Why?
|
Humans | 44 | 2022 | 755533 | 0.130 |
Why?
|
Visual Prosthesis | 1 | 2016 | 48 | 0.130 |
Why?
|
Injections, Intraocular | 1 | 2015 | 32 | 0.130 |
Why?
|
Injections, Intra-Arterial | 1 | 2015 | 182 | 0.130 |
Why?
|
Cat-Scratch Disease | 1 | 2015 | 23 | 0.130 |
Why?
|
Patient Selection | 2 | 2018 | 4254 | 0.130 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 559 | 0.130 |
Why?
|
Sertraline | 1 | 2016 | 208 | 0.130 |
Why?
|
Patient Positioning | 1 | 2017 | 326 | 0.120 |
Why?
|
Laser Coagulation | 1 | 2016 | 327 | 0.110 |
Why?
|
Pseudoxanthoma Elasticum | 1 | 2013 | 14 | 0.110 |
Why?
|
Angioid Streaks | 1 | 2013 | 14 | 0.110 |
Why?
|
Vitelliform Macular Dystrophy | 1 | 2013 | 17 | 0.110 |
Why?
|
Retrospective Studies | 18 | 2021 | 79686 | 0.110 |
Why?
|
Subretinal Fluid | 1 | 2013 | 24 | 0.110 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9109 | 0.110 |
Why?
|
Peptide Fragments | 2 | 2016 | 5087 | 0.110 |
Why?
|
Treatment Outcome | 11 | 2020 | 64535 | 0.110 |
Why?
|
Retinal Vein Occlusion | 1 | 2014 | 149 | 0.110 |
Why?
|
Treatment Failure | 2 | 2016 | 2637 | 0.110 |
Why?
|
Blindness | 1 | 2016 | 582 | 0.110 |
Why?
|
Aged, 80 and over | 13 | 2020 | 58549 | 0.100 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13577 | 0.100 |
Why?
|
Cataract Extraction | 1 | 2016 | 466 | 0.100 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2014 | 251 | 0.100 |
Why?
|
Geographic Atrophy | 1 | 2013 | 79 | 0.100 |
Why?
|
Bacteria | 3 | 2018 | 2175 | 0.100 |
Why?
|
Middle Aged | 20 | 2021 | 218055 | 0.100 |
Why?
|
Ceftazidime | 1 | 2011 | 57 | 0.100 |
Why?
|
Photography | 1 | 2014 | 531 | 0.100 |
Why?
|
Tobramycin | 1 | 2011 | 67 | 0.100 |
Why?
|
Drug Combinations | 2 | 2020 | 2011 | 0.090 |
Why?
|
Aged | 19 | 2020 | 167376 | 0.090 |
Why?
|
Medical Records | 1 | 2016 | 1403 | 0.090 |
Why?
|
Electroretinography | 1 | 2013 | 515 | 0.090 |
Why?
|
Ocular Hypotension | 1 | 2011 | 24 | 0.090 |
Why?
|
Retina | 3 | 2016 | 2626 | 0.090 |
Why?
|
Female | 25 | 2020 | 387920 | 0.090 |
Why?
|
Anterior Chamber | 1 | 2011 | 194 | 0.090 |
Why?
|
Welding | 1 | 2010 | 89 | 0.090 |
Why?
|
Retinal Necrosis Syndrome, Acute | 1 | 2010 | 24 | 0.090 |
Why?
|
Diplopia | 1 | 2011 | 214 | 0.080 |
Why?
|
Male | 24 | 2020 | 356577 | 0.080 |
Why?
|
Choroid Neoplasms | 1 | 2010 | 177 | 0.080 |
Why?
|
Eye Infections, Viral | 1 | 2010 | 60 | 0.080 |
Why?
|
Iris Neoplasms | 1 | 2009 | 13 | 0.080 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2011 | 239 | 0.080 |
Why?
|
Eye Color | 2 | 2006 | 36 | 0.080 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2009 | 61 | 0.080 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2011 | 338 | 0.080 |
Why?
|
Herpesviridae Infections | 1 | 2010 | 270 | 0.080 |
Why?
|
Nevus, Pigmented | 1 | 2010 | 221 | 0.080 |
Why?
|
Vancomycin | 1 | 2011 | 500 | 0.080 |
Why?
|
Eye Injuries | 1 | 2011 | 230 | 0.080 |
Why?
|
Cost Savings | 1 | 2013 | 916 | 0.080 |
Why?
|
Adult | 12 | 2020 | 217986 | 0.070 |
Why?
|
Philadelphia | 1 | 2008 | 269 | 0.070 |
Why?
|
Injections | 2 | 2010 | 830 | 0.070 |
Why?
|
Candida | 1 | 2008 | 165 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2214 | 0.070 |
Why?
|
Vision Disorders | 1 | 2013 | 1076 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2017 | 7342 | 0.070 |
Why?
|
Sex Distribution | 1 | 2011 | 2292 | 0.070 |
Why?
|
Device Removal | 1 | 2011 | 638 | 0.070 |
Why?
|
Morbidity | 1 | 2011 | 1762 | 0.060 |
Why?
|
Catheterization | 1 | 2011 | 1430 | 0.060 |
Why?
|
Hair Color | 1 | 2006 | 131 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 2015 | 2167 | 0.060 |
Why?
|
Acute Disease | 2 | 2017 | 7224 | 0.060 |
Why?
|
Reoperation | 2 | 2016 | 4283 | 0.060 |
Why?
|
India | 1 | 2011 | 2326 | 0.060 |
Why?
|
Antidepressive Agents | 1 | 2016 | 2886 | 0.060 |
Why?
|
Optic Disk | 2 | 2021 | 421 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10811 | 0.060 |
Why?
|
Drug Resistance, Bacterial | 1 | 2011 | 1042 | 0.060 |
Why?
|
Leisure Activities | 1 | 2005 | 305 | 0.060 |
Why?
|
Skin Pigmentation | 1 | 2006 | 277 | 0.060 |
Why?
|
Sunlight | 1 | 2005 | 334 | 0.060 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2013 | 1385 | 0.050 |
Why?
|
Geography | 1 | 2005 | 661 | 0.050 |
Why?
|
Double-Blind Method | 1 | 2017 | 12348 | 0.050 |
Why?
|
Microsurgery | 1 | 2008 | 781 | 0.050 |
Why?
|
Occupational Diseases | 1 | 2010 | 1484 | 0.050 |
Why?
|
Cataract | 1 | 2008 | 830 | 0.050 |
Why?
|
Risk Factors | 6 | 2011 | 73860 | 0.040 |
Why?
|
Time Factors | 3 | 2016 | 39961 | 0.040 |
Why?
|
Incidence | 4 | 2021 | 21239 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2010 | 3043 | 0.040 |
Why?
|
Disease Progression | 2 | 2018 | 13427 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2014 | 19987 | 0.030 |
Why?
|
Odds Ratio | 2 | 2006 | 9720 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2020 | 1574 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9180 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8555 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2011 | 21907 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1667 | 0.030 |
Why?
|
Occupational Exposure | 1 | 2005 | 1801 | 0.030 |
Why?
|
Glucocorticoids | 2 | 2014 | 2148 | 0.030 |
Why?
|
Arm | 1 | 2015 | 582 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2013 | 237 | 0.020 |
Why?
|
Retreatment | 1 | 2013 | 599 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3516 | 0.020 |
Why?
|
Anesthesia, Local | 1 | 2013 | 274 | 0.020 |
Why?
|
Microscopy, Acoustic | 1 | 2011 | 47 | 0.020 |
Why?
|
Coloring Agents | 1 | 2013 | 561 | 0.020 |
Why?
|
Prevalence | 1 | 2008 | 15589 | 0.020 |
Why?
|
Gonioscopy | 1 | 2011 | 155 | 0.020 |
Why?
|
Prospective Studies | 2 | 2013 | 53991 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2005 | 4358 | 0.020 |
Why?
|
Costs and Cost Analysis | 2 | 2013 | 1674 | 0.020 |
Why?
|
Ciliary Body | 1 | 2011 | 166 | 0.020 |
Why?
|
Sclera | 1 | 2011 | 189 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2009 | 5785 | 0.020 |
Why?
|
Aptamers, Nucleotide | 1 | 2010 | 173 | 0.020 |
Why?
|
Eicosapentaenoic Acid | 1 | 2013 | 611 | 0.020 |
Why?
|
Fluorocarbons | 1 | 2013 | 480 | 0.020 |
Why?
|
Drug Resistance | 1 | 2013 | 1611 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 2010 | 1031 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10538 | 0.020 |
Why?
|
Docosahexaenoic Acids | 1 | 2013 | 905 | 0.020 |
Why?
|
Suture Techniques | 1 | 2011 | 791 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2008 | 15576 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2010 | 1632 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 4017 | 0.020 |
Why?
|
United States | 3 | 2021 | 71888 | 0.020 |
Why?
|
Functional Laterality | 1 | 2010 | 2261 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 2004 | 284 | 0.010 |
Why?
|
Brachytherapy | 1 | 2010 | 1241 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2011 | 1661 | 0.010 |
Why?
|
Epidemiologic Research Design | 1 | 2004 | 367 | 0.010 |
Why?
|
Health Care Costs | 1 | 2013 | 3228 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12926 | 0.010 |
Why?
|
Siblings | 1 | 2004 | 826 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8487 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6481 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 41119 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1774 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29423 | 0.010 |
Why?
|
Aspirin | 1 | 2010 | 3347 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 5937 | 0.010 |
Why?
|
Pediatrics | 1 | 1971 | 3582 | 0.010 |
Why?
|
Educational Status | 1 | 2004 | 2509 | 0.010 |
Why?
|
Vitamins | 1 | 2004 | 1633 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2004 | 2228 | 0.010 |
Why?
|
Adolescent | 2 | 2017 | 87236 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2004 | 3998 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 58025 | 0.010 |
Why?
|
Sex Factors | 1 | 2004 | 10493 | 0.010 |
Why?
|
Professional Practice | 1 | 1971 | 311 | 0.010 |
Why?
|
Brain | 1 | 2015 | 26737 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36042 | 0.000 |
Why?
|
Smoking | 1 | 2004 | 9047 | 0.000 |
Why?
|
Body Mass Index | 1 | 2004 | 12838 | 0.000 |
Why?
|
Canada | 1 | 1971 | 2121 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2004 | 12200 | 0.000 |
Why?
|
Education, Medical, Graduate | 1 | 1971 | 2332 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2004 | 15651 | 0.000 |
Why?
|
Quality of Health Care | 1 | 1971 | 4364 | 0.000 |
Why?
|
Physicians | 1 | 1971 | 4558 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1971 | 26039 | 0.000 |
Why?
|
Infant | 1 | 1971 | 35867 | 0.000 |
Why?
|
Child, Preschool | 1 | 1971 | 41893 | 0.000 |
Why?
|
Child | 1 | 1971 | 79427 | 0.000 |
Why?
|
Concepts
(233)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_